|
ZNF434 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.72424313610509E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69529945637237E-10 |
| Normal-vs-Stage2 |
2.988800E-04 |
| Normal-vs-Stage3 |
9.46287492809006E-12 |
| Normal-vs-Stage4 |
1.88740023610023E-10 |
| Stage1-vs-Stage2 |
1.775630E-01 |
| Stage1-vs-Stage3 |
1.559890E-02 |
| Stage1-vs-Stage4 |
2.022100E-02 |
| Stage2-vs-Stage3 |
7.256100E-03 |
| Stage2-vs-Stage4 |
5.999900E-03 |
| Stage3-vs-Stage4 |
6.940400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90825133472572E-12 |
| Normal-vs-AfricanAmerican |
5.72469999999825E-05 |
| Normal-vs-Asian |
1.95300000005449E-06 |
| Caucasian-vs-AfricanAmerican |
9.909000E-01 |
| Caucasian-vs-Asian |
2.723200E-01 |
| AfricanAmerican-vs-Asian |
4.824200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.86770001873316E-09 |
| Normal-vs-Female |
3.62865293368486E-12 |
| Male-vs-Female |
4.858200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.7851003421614E-10 |
| Normal-vs-Age(41-60Yrs) |
5.10150033328216E-10 |
| Normal-vs-Age(61-80Yrs) |
1.17970000435008E-09 |
| Normal-vs-Age(81-100Yrs) |
4.246700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.173000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.065600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.879800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.974000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.180600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.038000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.90430000002184E-06 |
| Classical-VS-Follicular |
5.877700E-02 |
| Classical-VS-Other |
8.590200E-01 |
| Classical-VS-Normal |
9.87554482634323E-12 |
| Tall-VS-Follicular |
1.84969999983409E-07 |
| Tall-VS-Other |
1.285150E-01 |
| Tall-VS-Normal |
9.43689570931383E-15 |
| Follicular-VS-Other |
6.532800E-01 |
| Follicular-VS-Normal |
1.754390E-04 |
| Other-VS-Normal |
2.054200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.19199999765374E-08 |
| Normal-vs-N1 |
1.18570042673127E-10 |
| N0-vs-N1 |
1.300150E-02 |
|
|
